GSK3B and Parkinson disease: The abnormal increase in the level and activity of GSK-3β has been associated with neuronal death, paired helical filament tau formation, and neurite retraction in AD and in GSK-3β mediated 6-hydroxydopamine-induced neuronal death in in vitro and in vivo models of PD [12–14].